Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BiO2 Medical Inc.

www.bio2medical.com

Latest From BiO2 Medical Inc.

Venture Funding Deals, February 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research, Analytical Equipment and Supplies sectors. This month’s column covers deals announced December 2015 through January 2016.

BioPharmaceutical Medical Device

Medical Device Deals Update, February 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced December 2015-January 2016.

Medical Device Deals

Start-Up Previews, September 2013

This Month's Profile Group: Central Venous Access: Start-Ups Change The Standard Of Care, features profiles of Bio 2 Medical, Houston Medical Robotics, and Mirador Biomedical. Plus these Start-Ups Across Health Care: BioVerys, Clinmet, Eclipse Breast Health Technologies, and Sea Lane Biotechnologies.

BioPharmaceutical Medical Device

BiO2 Medical Inc.

Hospitalized patients are at the greatest risk for a fatal pulmonary embolism within the first 10 days after admission, but traditional inferior vena cava filters to prevent PEs if anticoagulant therapy is contraindicated and/or ineffective are not typically placed in a patient until approximately one week into their hospital stay. BiO2 Medical Inc. is looking to address this treatment gap with its Angel Catheter, a device that incorporates the PE protection of a retrievable, self-expanding nitinol IVC filter attached to a triple-lumen, central venous access catheter.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Cardiovascular
  • Respiratory, Pulmonary
  • Alias(es)
  • Artificial Airways Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BiO2 Medical Inc.
  • Senior Management
  • Christopher E Banas, Chmn. & CEO
    Luis F Angel, MD, Pres. & CMO
    Chad Frederickson, VP, Mktg. & Fin.
    Patrick Howe, EVP, Sales
    Jeff Steinmetz, VP, R&D
  • Contact Info
  • BiO2 Medical Inc.
    Phone: (210) 694-5222
    18618 Tuscany Stone, Ste. 100
    San Antonio, TX 78258
    USA
UsernamePublicRestriction

Register